Eli Lilly CEO David Ricks is pushing back against the Trump administration’s plan to impose tariffs on pharmaceutical products made outside the US. This move would significantly impact global supply chains and could lead to increased prices for consumers. Ricks has repeatedly expressed his concerns over the plan, which he believes would be detrimental to the industry and its stakeholders.
Source: https://endpts.com/lilly-ceo-ricks-urges-trump-to-drop-drug-tariff-plan